idiopathic pulmonary fibrosis

Serum osteoprotegerin and fibulin-1 levels negatively correlate with DLCO in IPF
Habibie Habibie, Janette Burgess, Marissa Wisman, Marnix Jonker, Mirjam Kool, Marlies Wijsenbeek, Nicolas Kahn, Michael Kreuter, Barbro N. Melgert

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4702; DOI: 10.1183/13993003.congress-2019.PA4702
The utilization pattern of surgical lung biopsies (SLB) for the diagnosis of interstitial lung diseases (ILD) in Sri Lanka
Amila Rathnapala, S Wickramasinghe, D Tilakaratne, H Chreif, S Palihawadana, D Handagala, E Perera, S Kularatne, B Gunasena, R Punchihewa

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4719; DOI: 10.1183/13993003.congress-2019.PA4719
Possible role of chest ultrasonography for the evaluation of peripheral fibrotic changes in patients affected by IPF
Andrea Smargiassi, Riccardo Inchingolo, Francesco Lombardi, Angelo Calabrese, Matteo Siciliano, Gino Soldati, Luca Richeldi

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4827; DOI: 10.1183/13993003.congress-2019.PA4827
A registry of patients with idiopathic pulmonary fibrosis in Russia: 2-yr results and therapeutic modalities in real-life practice
Svetlana Yu. Chikina, Sergey Avdeev, Andrey Belevsky, Alexander Cherniak, Natalia Kravchenko

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4711; DOI: 10.1183/13993003.congress-2019.PA4711
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Voon Shiong Ronnie Tan, Sok Boon Tay, Felicia Teo, Pipetius Quah, Lynette Teo, Ching Ching Ong, Ju Ee Seet, Tow Keang Lim

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4693; DOI: 10.1183/13993003.congress-2019.PA4693
Revised UIP/IPF diagnoses after the 2018 international guidelines: a 15-year Padova-Strasbourg experience
Fiorella Calabrese, Francesca Lunardi, Elisabetta Balestro, Elisabetta Cocconcelli, Chiara Giraudo, Roberta Polverosi, Eleonora Faccioli, Federico Rea, Antonin Fattori, Marie-Pierrette Chenard, Mickael Ohana, Aissam Labani, Romain Kessler, Sandrine Hirschi

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4712; DOI: 10.1183/13993003.congress-2019.PA4712
Best tolerated dose of Pirfenidone in patients with idiopathic pulmonary fibrosis
Neha Agrawal, Preyas J Vaidya, Vinod B Chavhan, Tejashree T Lele, Anne Leuppi-Taegtmeyer, Joerg D Leuppi, Prashant N Chhajed

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4707; DOI: 10.1183/13993003.congress-2019.PA4707
Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland
Katarzyna B. Lewandowska, Piotr Radwan-Rohrenschef, Malgorzata Sobiecka, Malgorzata Bartosiewicz, Izabela Siemion-Szczesniak, Stefan Wesolowski, Iwona Bestry, Agata Gladzka, Dorota Klatka, Jan Kus

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4716; DOI: 10.1183/13993003.congress-2019.PA4716
Antifibrotic treatment in 18 patients with chronic Hypersensitivity Pneumonitis
Vasilios Tzilas, Argyrios Tzouvelekis, Evangelos Bouros, Matthew Katsaras, Maria Ntassiou, Theodoros Karampitsakos, Demosthenes Bouros

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4733; DOI: 10.1183/13993003.congress-2019.PA4733
Health-related quality of life development in IPF versus other ILD – the HILDA study
Boglárka Szentes, Phillen Maqhuzu, Michael Kreuter, Thomas Bahmer, Martin Claussen, Larissa Schwarzkopf

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4722; DOI: 10.1183/13993003.congress-2019.PA4722

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us